Activation of the complement system by pathogenic fungi.
about
Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphaeHost response to Candida albicans bloodstream infection and sepsisAnti-Immune Strategies of Pathogenic FungiAspergillus fumigatus and aspergillosisFactor H Binds to Extracellular DNA Traps Released from Human Blood Monocytes in Response to Candida albicans.Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.Bivalency is required for anticapsular monoclonal antibodies to optimally suppress activation of the alternative complement pathway by the Cryptococcus neoformans capsule.Cytokines regulate complement receptor immunoglobulin expression and phagocytosis of Candida albicans in human macrophages: A control point in anti-microbial immunity.A sensitive high-throughput assay for evaluating host-pathogen interactions in Cryptococcus neoformans infectionInteractions of Penicillium marneffei with human leukocytes in vitro.Antibody interactions with the capsule of Cryptococcus neoformansInterdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.Lymphocyte transformation assay for C neoformans antigen is not reliable for detecting cellular impairment in patients with neurocryptococcosisLinkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycansActivation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.Immunoglobulins G, M, and A against Sporothrix schenckii exoantigens in patients with sporotrichosis before and during treatment with itraconazole.Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy.Activation of the alternative complement pathway in canine normal serum by Paracoccidioides brasiliensisComplement C3 plays an essential role in the control of opportunistic fungal infections.Characterization of a flocculation-like phenotype in Cryptococcus neoformans and its effects on pathogenesis.Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain.App1: an antiphagocytic protein that binds to complement receptors 3 and 2.Complement Attack against Aspergillus and Corresponding Evasion Mechanisms.Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidisThe yeast Candida albicans binds complement regulators factor H and FHL-1.The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein.Role of complement in protection against Cryptococcus gattii infection.Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina.Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice.Cryptococcal pathogenic mechanisms: a dangerous trip from the environment to the brain.
P2860
Q24290929-93AD3226-5747-4285-8E67-03011A33B747Q27028066-179941D9-3FEE-4187-AE73-D9292677484DQ28071716-CC7B113D-801A-480D-BBA0-425F877EECF5Q29617908-4707CE4A-9491-4A65-B16E-BBB88A7667A8Q30834832-09E8CF28-B9D6-4312-9106-E86F927B08A3Q33693515-F759BFFE-B4DB-4F9E-A1C0-A19072FEC28BQ33752377-7B9DAF30-5EAE-41C3-AEF4-D19D58442809Q33825976-EC6FA553-7CE8-4A1E-8BFE-944DC20652E9Q33987858-E7526C7C-20B9-4E36-9496-40546DFF9C07Q34001823-4D38C64C-782D-4FFA-A273-AA9569D5BECEQ34004832-7CC0F4B3-523F-41E7-9B63-B97E784E88D1Q34009212-8C09A389-571C-4423-BE82-73BFB37D8905Q34121516-684D1FC2-0D0E-4995-81B2-6A8B94DF330CQ34125581-F296679B-84B5-481E-934A-1773AD659649Q34461657-72DE5624-DEB7-4C11-B30A-18FAB3B196EDQ35187024-1D1E7051-FBA6-44FA-83E3-E2DFC91CC390Q35547013-F86B6168-A0BB-442C-BA9B-79ABA7E05B4EQ36095151-3FE77D6A-42CD-4F90-8A65-30ECB9B684DDQ36376827-E062F28E-5729-4BA0-B10F-526EF767C001Q37162025-B816C0BC-8818-40C4-9A94-E0DA335AC072Q37333509-CD072D31-F8EE-46A5-87BE-FE0F1DEF94FFQ37350575-848DB8FA-A67E-4D4B-B1BC-D97D23909FD9Q37523959-701D9708-1278-46D5-84C7-FE650485DA5DQ37551491-BC2087DA-78F1-4CE7-BE51-747D9B089AD8Q38038600-01267091-9978-4249-BE23-DF675D3F8848Q38342684-2EBF7238-25A5-43F3-9115-F27A78FF2368Q39656217-27BD6301-DA00-441D-8942-B5545D7BC894Q40204670-D6CCE455-0074-422B-84E1-E6355413E79FQ43179847-A9A773E8-1D11-4B98-8721-D0C5605240ECQ45192226-E9EF9E3B-5E93-48AB-BA45-168AAEA297A1Q47129863-CC6A3F0A-53D2-411E-A519-7EA87FE3D3CAQ52580472-1A7C1DEE-FE33-463B-A66D-DC8CDAFC7B97
P2860
Activation of the complement system by pathogenic fungi.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Activation of the complement system by pathogenic fungi.
@en
Activation of the complement system by pathogenic fungi.
@nl
type
label
Activation of the complement system by pathogenic fungi.
@en
Activation of the complement system by pathogenic fungi.
@nl
prefLabel
Activation of the complement system by pathogenic fungi.
@en
Activation of the complement system by pathogenic fungi.
@nl
P2860
P1476
Activation of the complement system by pathogenic fungi.
@en
P2860
P407
P577
1996-01-01T00:00:00Z